David Moore

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis

Tuberculosis preventive therapy: scientific and ethical considerations for trials of ultra-short regimens

Knowledge, Attitudes, and Practices toward Chagas Disease: A Cross-Sectional Survey of Bolivians in the Gran Chaco and Latin American Migrants in London

<scp>HIV</scp> in Latin American migrants in the UK: A neglected population in the 95‐95‐95 targets

Unmasking rifampicin mono-resistance in tuberculosis patients in Cross River State, Nigeria

Community-based serological screening for Chagas disease in London: a cross-sectional, observational pilot study

Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach

Second Primary Lung Cancer – An Emerging Issue in Lung Cancer Survivors

Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer

Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru

Rare in the country, not in the community: Chagas disease in the Latin American diaspora

Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial

Preventive therapy: can tuberculosis efforts learn anything from the leprosy approach?

Impact of a multicomponent strategy including decentralized molecular testing for tuberculosis on mortality: planned analysis of a cluster-randomized trial in Uganda

Second Primary Lung Cancer—Potential Areas of Ambiguity

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer

Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?

Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV

Integrating Molecular Diagnostics and GIS Mapping: A Multidisciplinary Approach to Understanding Tuberculosis Disease Dynamics in South Africa Using Xpert MTB/RIF

Human Cytomegalovirus Immunoglobulin G Response and Pulmonary Tuberculosis in Adolescents: A Case-Control Study

SARS-CoV-2 infection and pulmonary tuberculosis in children and adolescents: a case-control study

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas

TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region

Understanding the biology, morbidity and social contexts of adolescent tuberculosis: a prospective observational cohort study protocol (Teen TB)

Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru

Alternative cost-effective media to facilitate MODS culture for diagnostics of tuberculosis